Literature DB >> 9325019

The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor.

R De Jongh1, J Vranken, G Vundelinckx, E Bosmans, M Maes, R Heylen.   

Abstract

Levels of plasma cytokines, their receptors or immune-related peptides, are used in experimental and clinical medicine. However, no standards are available regarding the use of anticoagulants or blood processing including the technique of blood collection or time delay between blood sampling and centrifugation. Blood was collected from 10 patients in order to assay interleukin 6, soluble interleukin 6 receptor, soluble interleukin 2 receptor and soluble transferrin receptor by enzyme-linked immunosorbent assay (ELISA). At the time of sampling, five different collecting tubes were used: allowing coagulation, in the presence of EDTA, with EDTA being administered to the serum after its separation, in citrated and in heparinized blood. Blood was centrifuged 10 min after collection and separated serum or plasma was immediately frozen at -20 degrees C. To study the effect of time delay between blood sampling and processing, blood from 11 other patients was sampled, allowing coagulation; or in EDTA tubes and stored at 4 degrees C. The blood was centrifuged 10 min, 8 h and 24 h later, and the separated serum or EDTA plasma was stored at -20 degrees C until thawed for protein determination. Plasma interleukin 6 and soluble interleukin 6 receptor concentrations did not depend on the type of anticoagulant used or the time delay between sampling and processing. Soluble interleukin 2 receptor concentrations were not influenced by time delay before centrifugation, but concentrations were increased 10-fold in EDTA plasma exclusively when EDTA had contact with blood cells. Soluble transferrin receptor concentrations rose progressively with storage time before centrifugation. Contact of EDTA to whole blood or serum resulted in the same increase of soluble transferrin receptor concentration. The results suggest that standardization of the use of anticoagulant and time delay before centrifugation and serum or plasma separation is necessary for soluble interleukin 2 receptor and soluble transferrin receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325019     DOI: 10.1006/cyto.1997.0217

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

1.  The overactive bladder.

Authors:  Richard Foon; Marcus J Drake
Journal:  Ther Adv Urol       Date:  2010-08

Review 2.  Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.

Authors:  Fotini Betsou; Elaine Gunter; Judith Clements; Yvonne DeSouza; Katrina A B Goddard; Fiorella Guadagni; Wusheng Yan; Amy Skubitz; Stella Somiari; Trina Yeadon; Rodrigo Chuaqui
Journal:  J Mol Diagn       Date:  2012-11-27       Impact factor: 5.568

3.  Discriminative value of inflammatory biomarkers for suspected sepsis.

Authors:  Ephraim L Tsalik; L Brett Jaggers; Seth W Glickman; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Vance G Fowler; Charles B Cairns; Stephen F Kingsmore; Christopher W Woods
Journal:  J Emerg Med       Date:  2011-11-06       Impact factor: 1.484

4.  Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions.

Authors:  Najib Aziz; Roger Detels; Joshua J Quint; Qian Li; David Gjertson; Anthony W Butch
Journal:  Cytokine       Date:  2016-05-18       Impact factor: 3.861

5.  Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies.

Authors:  Deborah E Citrin; Ying J Hitchcock; Eun Joo Chung; Jonathan Frandsen; Mary Ellen Urick; William Shield; David Gaffney
Journal:  Radiat Oncol       Date:  2012-04-26       Impact factor: 3.481

6.  Temporal reliability of cytokines and growth factors in EDTA plasma.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Annika Idahl; Göran Hallmans; Karen L Koenig; Adele M Marrangoni; Brian M Nolen; Nina Ohlson; Anne Zeleniuch-Jacquotte; Eva Lundin
Journal:  BMC Res Notes       Date:  2010-11-13

7.  Blood Substrate Collection and Handling Procedures under Pseudo-Field Conditions: Evaluation of Suitability for Inflammatory Biomarker Measurement.

Authors:  Karen Sugden; Andrea Danese; Idan Shalev; Benjamin S Williams; Avshalom Caspi
Journal:  Biodemography Soc Biol       Date:  2015

Review 8.  Cytokines as biomarkers in rheumatoid arthritis.

Authors:  Agata Burska; Marjorie Boissinot; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-09       Impact factor: 4.711

9.  Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.

Authors:  Raphael Hesse; Anke Wahler; Pauline Gummert; Stefanie Kirschmer; Markus Otto; Hayrettin Tumani; Jan Lewerenz; Cathrin Schnack; Christine A F von Arnim
Journal:  BMC Neurol       Date:  2016-09-26       Impact factor: 2.474

10.  Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group.

Authors:  Fay Betsou; Alexandre Bulla; Sang Yun Cho; Judith Clements; Rodrigo Chuaqui; Domenico Coppola; Yvonne De Souza; Annemieke De Wilde; William Grizzle; Fiorella Guadagni; Elaine Gunter; Stacey Heil; Verity Hodgkinson; Joseph Kessler; Michael Kiehntopf; Hee Sung Kim; Iren Koppandi; Katheryn Shea; Rajeev Singh; Marc Sobel; Stella Somiari; Demetri Spyropoulos; Mars Stone; Gunnel Tybring; Klara Valyi-Nagy; Gert Van den Eynden; Lalita Wadhwa
Journal:  Biopreserv Biobank       Date:  2016-04-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.